Episode

Celine Halioua - Making dogs live longer so humans can too

Podcast
Free Radicals
Published
Nov 18, 2025
Duration seconds
2877
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/danielshur/episodes/Celine-Halioua---Making-dogs-live-longer-so-humans-can-too-e3b4260
Audio
https://anchor.fm/s/107b5162c/podcast/play/111330944/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-10-18%2F412674856-44100-2-b027888768eec.mp3
JSON
/v1/public/podcasts/free-radicals-7588534/episodes/celine-halioua-making-dogs-live-longer-so-humans-can-too
Markdown
/podcast/free-radicals-7588534/celine-halioua-making-dogs-live-longer-so-humans-can-too.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/free-radicals-7588534/episodes/celine-halioua-making-dogs-live-longer-so-humans-can-too/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/free-radicals-7588534/celine-halioua-making-dogs-live-longer-so-humans-can-too.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Celine Halioua is the Founder & CEO of Loyal - the first company to ever receive FDA approval to develop a drug to extend lifespan in dogs, and they have raised $125mm from Bain Capital Ventures, Khosla Ventures, First Round and others to do so. By building a blockbuster longevity drug for dugs, Loyal aims to lay the foundation for safe and effective longevity drugs in humans. In this interview, Celine describes her thesis that longevity drugs should be boring, what it means to create a new market, how charlatans put the whole longevity field at risk, and much more. We hope you enjoy this episode.